Chain Pharmacy

FDA is receiving insufficient information and has limited authority to enforce REMS, says OIG report

FDA approved bed aquiline tablets late last year for the treatment of pulmonary multi-drug-resistant tuberculosis.

A survey of new Rx, new generic, and new OTC products

Smartphones do more than keep you in contact with friends and family. A slew of apps can help both you and your patients manage health better

The National Association of Chain Drug Stores (NACDS) Foundation has selected author and business consultant Jim Collins to serve as the keynote speaker for the 2013 NACDS Total Store Expo, which will debut August 10-13, 2013 in Las Vegas.

Five facets of the OxyContin dilemma

A longtime RPh ponders the midlife cost of her new PharmD degree.

A look at what's going on with the Continuing Professional Development initiative from ACPE.

A round-up of OTC products that provide fresh breath and help promote good oral health.

We can learn from New Zealand, Japan, and Pakistan

In 2012, FDA achieved a milestone with the approval of 39 innovative drug therapies for populations in need.

After years of declining pipeline productivity, are we headed for a resurgence in new approvals? Here's a look at what's ahead for 2013.

Intravenous abuse of Opana ER may be at risk of thrombotic thrombocytopenic purpura according to a report published in MMWR.

According to the numbers, at-home test kits are going to continue to be an area of market growth.

A new bimonthly column from Ken Baker looks at ethical decision-making in pharmacy.

NSAIDs plus ACE inhibitors or ARBs can increase risk of kidney injury for patients taking diuretics.

Recent data were released on a long-term, open-label extension study evaluating clobazam for the adjunctive treatment of drop seizures.

Pharmacy techs speak out.